Cancer : why do we feel that everything is accelerating?

For any patient or loved one affected by cancer, every headline announcing a "breakthrough" is much more than information—it is a promise. February 2026 has been saturated with such hopes. From Dr. Barbacid’s publications in Spain to new CRISPR tests in Shenzhen, the impression of a sudden, massive acceleration dominates the conversation. Yet, behind this sense of a "Big Bang" lies a more subtle reality: cancer is not moving faster; it is our capacity to query it that has changed dimension.

The acceleration is technological, not biological

Biological life is immensely complex, and human biology does not follow the exponential rhythm of computer processors. What we are witnessing today is not a "series of miracles," but a radical transformation of our experimental power.

Consider the recent collaboration between Ginkgo Bioworks and OpenAI: by using an AI-driven laboratory, they were able to conduct over 36,000 protein synthesis experiments autonomously in just six months. This massive volume allows researchers to test, in a matter of months, hypotheses that would have previously required years of manual human labor. We haven't found "the cure" overnight; rather, the speed of testing has been multiplied a thousandfold.

The risk of "noise" : The Barbacid Effect

The recent story of Dr. Mariano Barbacid perfectly illustrates this gap. His research on a "triple therapy" successfully eliminated pancreatic tumors in 45 mice without any signs of resistance. The announcement triggered a media tidal wave, forcing the researchers to temper expectations: "We have tried to make it clear that this is in mice," they lamented as they were overwhelmed by messages from desperate patients.

This distortion is amplified by an informational landscape that is now increasingly fragmented. The official withdrawal of the United States from the WHO on January 22, 2026, did not stop research, but it has weakened the coordination of public perception. In the age of social media, scientific coordination remains rigorous through peer-reviewed journals, but the coordination of public perception has frayed. Every "weak signal" is amplified by algorithms hungry for sensationalism, creating the illusion of an immediate cure where there is only a promising early path.

Distinguishing the timeframes of progress

To maintain a clear perspective, we must distinguish between three realities currently colliding:

• Clinical Maturity (The long term): The FDA approval on February 12, 2026, of Optune Pax for locally advanced pancreatic cancer is the culmination of decades of rigorous clinical studies. This wearable device uses Tumor Treating Fields (TTFields) to physically disrupt cancer cell division. Here, the progress is real, measured, and ready for the patient’s bedside.
• Laboratory Hope (The mid-term): Work at KAIST in Korea regarding the "reprogramming" of colon cancer cells back to a healthy state, or the sub-attomolar CRISPR sensors in Shenzhen, represent fascinating conceptual revolutions. However, it is vital to remember that the vast majority of laboratory successes never cross the barrier of human clinical trials.
• The Digital Instant (The noise): Algorithms transform technical publications into viral hashtags, overlooking the fact that validation remains slow because the complexity of the living world demands patience.

Galeon’s Mission : Making validation as robust as discovery

While discovery is accelerating thanks to AI and CRISPR, clinical validation remains the primary bottleneck. We do not treat patients with probabilities; we treat them with proof.

Why is this process still so slow? Because 80% of the data generated in hospitals today is unusable, locked in unstructured silos. To prove that a new molecular switch or an mRNA vaccine works effectively across thousands of different genetic profiles, we need a "clean" and secure data infrastructure.

This is where Galeon steps in. We are not here to announce miracles, but to build the necessary lever—the Smart Patient Record—that transforms millions of hypotheses into clinical realities. Through Blockchain Swarm Learning®, we enable researchers to validate their findings on real-world data at scale, without compromising security or privacy.

Let us remain passionate about the future, but stay demanding of the proof.

‍